Tokyo - Delayed Quote JPY

Medical Ikkou Group Co.,Ltd. (3353.T)

2,464.00 +1.00 (+0.04%)
At close: May 17 at 3:10 PM GMT+9
Loading Chart for 3353.T
DELL
  • Previous Close 2,463.00
  • Open 2,464.00
  • Bid --
  • Ask --
  • Day's Range 2,464.00 - 2,464.00
  • 52 Week Range 2,025.00 - 2,904.00
  • Volume 300
  • Avg. Volume 2,830
  • Market Cap (intraday) 9.26B
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) 9.50
  • EPS (TTM) 259.46
  • Earnings Date Apr 5, 2024
  • Forward Dividend & Yield 50.00 (2.03%)
  • Ex-Dividend Date Aug 29, 2024
  • 1y Target Est --

Medical Ikkou Group Co.,Ltd. operates dispensing pharmacies in Japan. It operates 95 dispensing pharmacy stores; 42 residential care facilities, such as paid nursing homes and group homes; and home-based care offices comprising 22 offices that offers day services and 6 home-visit care offices. The company is also involved in the rental of welfare equipment; pharmaceutical wholesale business; and rental of hotels and hospitals, as well as invests in listed and unlisted stocks, M&A, etc. Medical Ikkou Group Co.,Ltd. was founded in 1980 and is headquartered in Tsu, Japan.

www.m-ikkou.co.jp

--

Full Time Employees

February 29

Fiscal Year Ends

Recent News: 3353.T

Performance Overview: 3353.T

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

3353.T
20.69%
Nikkei 225
15.91%

1-Year Return

3353.T
10.70%
Nikkei 225
28.89%

3-Year Return

3353.T
4.40%
Nikkei 225
39.40%

5-Year Return

3353.T
42.11%
Nikkei 225
82.53%

Compare To: 3353.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 3353.T

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    9.26B

  • Enterprise Value

    12.37B

  • Trailing P/E

    9.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.25

  • Price/Book (mrq)

    0.72

  • Enterprise Value/Revenue

    0.33

  • Enterprise Value/EBITDA

    7.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.60%

  • Return on Assets (ttm)

    3.29%

  • Return on Equity (ttm)

    8.17%

  • Revenue (ttm)

    39.9B

  • Net Income Avi to Common (ttm)

    1.04B

  • Diluted EPS (ttm)

    259.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.7B

  • Total Debt/Equity (mrq)

    69.20%

  • Levered Free Cash Flow (ttm)

    1.29B

Research Analysis: 3353.T

Company Insights: 3353.T

Research Reports: 3353.T

People Also Watch